[go: up one dir, main page]

ZA200810600B - Treatment of tumors in pediatric patients with epidermal growth factor receptor antagonists - Google Patents

Treatment of tumors in pediatric patients with epidermal growth factor receptor antagonists

Info

Publication number
ZA200810600B
ZA200810600B ZA200810600A ZA200810600A ZA200810600B ZA 200810600 B ZA200810600 B ZA 200810600B ZA 200810600 A ZA200810600 A ZA 200810600A ZA 200810600 A ZA200810600 A ZA 200810600A ZA 200810600 B ZA200810600 B ZA 200810600B
Authority
ZA
South Africa
Prior art keywords
tumors
treatment
growth factor
receptor antagonists
factor receptor
Prior art date
Application number
ZA200810600A
Other languages
English (en)
Inventor
Rowinsky Eric
Original Assignee
Imclone Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imclone Systems Inc filed Critical Imclone Systems Inc
Publication of ZA200810600B publication Critical patent/ZA200810600B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200810600A 2006-07-27 2008-12-15 Treatment of tumors in pediatric patients with epidermal growth factor receptor antagonists ZA200810600B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83348706P 2006-07-27 2006-07-27

Publications (1)

Publication Number Publication Date
ZA200810600B true ZA200810600B (en) 2009-11-25

Family

ID=38982334

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200810600A ZA200810600B (en) 2006-07-27 2008-12-15 Treatment of tumors in pediatric patients with epidermal growth factor receptor antagonists

Country Status (15)

Country Link
EP (1) EP2043688A4 (fr)
JP (1) JP2009544736A (fr)
KR (1) KR20090033841A (fr)
CN (1) CN101484186A (fr)
AU (1) AU2007279261A1 (fr)
BR (1) BRPI0712368A2 (fr)
CA (1) CA2654911A1 (fr)
CR (1) CR10486A (fr)
EA (1) EA200870603A1 (fr)
EC (1) ECSP089011A (fr)
MX (1) MX2008016187A (fr)
NO (1) NO20085182L (fr)
TN (1) TNSN08512A1 (fr)
WO (1) WO2008014386A2 (fr)
ZA (1) ZA200810600B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA202192413A1 (ru) * 2019-03-27 2021-12-30 Нэшнл Рисеч Каунсил Оф Канада АНТИТЕЛА ПРОТИВ EGFRvIII И ИХ АНТИГЕНСВЯЗЫВАЮЩИЕ ФРАГМЕНТЫ

Also Published As

Publication number Publication date
CR10486A (es) 2009-02-23
ECSP089011A (es) 2009-01-30
JP2009544736A (ja) 2009-12-17
MX2008016187A (es) 2009-01-20
CA2654911A1 (fr) 2008-01-30
KR20090033841A (ko) 2009-04-06
BRPI0712368A2 (pt) 2012-06-05
CN101484186A (zh) 2009-07-15
EA200870603A1 (ru) 2009-06-30
WO2008014386A2 (fr) 2008-01-31
TNSN08512A1 (en) 2010-04-14
EP2043688A4 (fr) 2009-11-11
AU2007279261A1 (en) 2008-01-31
EP2043688A2 (fr) 2009-04-08
WO2008014386A3 (fr) 2008-07-03
NO20085182L (no) 2009-04-24

Similar Documents

Publication Publication Date Title
IL281715A (en) Activin-ActrIIA antagonists and their use to increase bone growth in cancer patients
IL211952A0 (en) Implantable device for the delivery of risperidone and methods of use thereof
EP2131919A4 (fr) Dispositif implantable destiné à communiquer avec le tissu biologique
PT2426148E (pt) Anticorpo anti-rá-il-3 para se utilizar no tratamento de tumores do sangue
PL2205185T3 (pl) Urządzenie do wytwarzania zakotwiczenia w tkance ludzkiej lub zwierzęcej
PT2282758T (pt) Anticorpos e vacinas para uso em métodos terapêuticos e diagnósticos para perturbações relacionadas com a alfa-sinucleína
IL230911A0 (en) A system for the treatment of heart tissue and its use
SG10201500140VA (en) Human antibodies against human tissue factor
SG10201604988YA (en) Methods and compositions for diagnostic use in cancer patients
IL197157A0 (en) Method for evaluating patients for treatment with drugs targeting ret receptor tyrosine kinase
IL205246A0 (en) Methods and compositions for diagnostic use in cancer patients
ZA200708755B (en) Use of an epidermal growth factor receptor kinase inhibator (EGFR) in gefitinib resistant patients
PL2227210T3 (pl) Łóżko pacjenta z urządzeniem nadzorującym i terapeutycznym
ZA201102949B (en) Implantable device for the delivery of octreotide and methods of use thereof
IL218851A0 (en) Use of dimiracetam in the treatment of chronic pain
HUE031337T2 (hu) Opioidok rezisztens rákos betegek kezelésében történõ alkalmazásra
EP2271267A4 (fr) Dispositifs médicaux pour administrer des fluides pendant une chirurgie et leurs procédés d'utilisation
GB2457321B (en) Illumination apparatus for use in examining a body of living tissues
GB2463474B (en) Therapeutic bone growth and regeneration
GB0822486D0 (en) Compounds for use in the treatment of pain
GB0908875D0 (en) Depsipeptides and their therapeutic use
ZA200810600B (en) Treatment of tumors in pediatric patients with epidermal growth factor receptor antagonists
EP2124950A4 (fr) Traitement d'une douleur avec de la naloxone
GB0710277D0 (en) Use of antivirals in the treatment of medical disorders
GB2460180B (en) Depsipeptides and their therapeutic use